Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MOOG INC. Capital/Financing Update 2015

Mar 31, 2015

30876_rns_2015-03-31_f036fb3d-f92e-41a8-b4c3-e4c78d34bc3b.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

8-K 1 a032715.htm 8-K html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document created using Wdesk 1 Copyright 2015 Workiva 03.27.15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 27, 2015

MOOG INC.

(Exact name of registrant as specified in its charter)

New York 1-5129 16-0757636
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
East Aurora, New York 14052-0018
(Address of principal executive offices) (Zip Code)

Registrant’s Telephone Number, Including Area Code: (716) 652-2000

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On March 27, 2015, Moog Inc. completed the sale of the assets of Moog Medical Devices Rochester, located in Rush, NY and MMC Sterilization, located in Erie, PA, for an undisclosed sum. This business has been reported within the Medical Devices segment. Combined sales of the businesses for fiscal 2014 were approximately $7 million. There is an estimated $.04 after-tax loss per share generated from this sale, which will be reflected in the Company's second quarter results for the period ended April 4, 2015.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

By: MOOG INC. — /s/ Jennifer Walter
Name: Jennifer Walter
Controller